

Cover Story
Free
With a simplified tech transfer agreement, six industry partners and 15 compounds (but no dedicated research funds), NCI challenges investigators to think creatively.
In Brief


Drugs & Targets


Trending Stories
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Otis Brawley looks back on a year of great science and greater challenges
- Twitter star Vinay Prasad retires @VinayPrasadMD
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- Dana-Farber to pay $15M to U.S. government in research fraud settlement











